BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brunton S. Current face of acute otitis media: microbiology and prevalence resulting from widespread use of heptavalent pneumococcal conjugate vaccine. Clin Ther 2006;28:118-23. [PMID: 16490585 DOI: 10.1016/j.clinthera.2006.01.011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Perez Vidakovics ML, Riesbeck K. Virulence mechanisms of Moraxella in the pathogenesis of infection. Curr Opin Infect Dis 2009;22:279-85. [PMID: 19405217 DOI: 10.1097/qco.0b013e3283298e4e] [Cited by in Crossref: 37] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
2 Corbeel L. What is new in otitis media? Eur J Pediatr 2007;166:511-9. [PMID: 17364173 DOI: 10.1007/s00431-007-0461-8] [Cited by in Crossref: 47] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
3 Newall AT, Creighton P, Philp DJ, Wood JG, Macintyre CR. The potential cost-effectiveness of infant pneumococcal vaccines in Australia. Vaccine 2011;29:8077-85. [DOI: 10.1016/j.vaccine.2011.08.050] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
4 Olwagen CP, Adrian PV, Nunes MC, Madhi SA. Evaluation of the association of pneumococcal conjugate vaccine immunization and density of nasopharyngeal bacterial colonization using a multiplex quantitative polymerase chain reaction assay. Vaccine 2018;36:3278-85. [DOI: 10.1016/j.vaccine.2018.04.068] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
5 Kwambana-Adams B, Hanson B, Worwui A, Agbla S, Foster-Nyarko E, Ceesay F, Ebruke C, Egere U, Zhou Y, Ndukum M, Sodergren E, Barer M, Adegbola R, Weinstock G, Antonio M. Rapid replacement by non-vaccine pneumococcal serotypes may mitigate the impact of the pneumococcal conjugate vaccine on nasopharyngeal bacterial ecology. Sci Rep 2017;7:8127. [PMID: 28811633 DOI: 10.1038/s41598-017-08717-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
6 Talbird SE, Taylor TN, Caporale J, Ismaila AS, Gomez J. Residual economic burden of Streptococcus pneumoniae- and nontypeable Haemophilus influenzae- associated disease following vaccination with PCV-7: A multicountry analysis. Vaccine 2010;28:G14-22. [DOI: 10.1016/j.vaccine.2010.06.080] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
7 Erwin AL, Smith AL. Nontypeable Haemophilus influenzae: understanding virulence and commensal behavior. Trends Microbiol 2007;15:355-62. [PMID: 17600718 DOI: 10.1016/j.tim.2007.06.004] [Cited by in Crossref: 117] [Cited by in F6Publishing: 107] [Article Influence: 7.8] [Reference Citation Analysis]
8 Talbird SE, Ismaila AS, Taylor TN. A steady-state, population-based model to estimate the direct and indirect effects of pneumococcal vaccines. Vaccine 2010;28:G3-G13. [DOI: 10.1016/j.vaccine.2010.06.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
9 Hedrick JA. Community-acquired upper respiratory tract infections and the role of third-generation oral cephalosporins. Expert Rev Anti Infect Ther 2010;8:15-21. [PMID: 20014898 DOI: 10.1586/eri.09.115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
10 Stone KC, Dagan R, Arguedas A, Leibovitz E, Wang E, Echols RM, Janjic N, Critchley IA. Activity of faropenem against middle ear fluid pathogens from children with acute otitis media in Costa Rica and Israel. Antimicrob Agents Chemother 2007;51:2230-5. [PMID: 17387157 DOI: 10.1128/AAC.00049-07] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
11 Petrofsky J, Berk L, Al-Nakhli H. The influence of autonomic dysfunction associated with aging and type 2 diabetes on daily life activities. Exp Diabetes Res 2012;2012:657103. [PMID: 22566994 DOI: 10.1155/2012/657103] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
12 Wang MC, Wang YP, Chu CH, Tu TY, Shiao AS, Chou P. Impact of pneumococcal conjugate vaccine on pediatric tympanostomy tube insertion in partial immunized population. ScientificWorldJournal 2015;2015:248678. [PMID: 25839052 DOI: 10.1155/2015/248678] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Choi SS, Lander L. Pediatric acute mastoiditis in the post-pneumococcal conjugate vaccine era. Laryngoscope 2011;121:1072-80. [PMID: 21520127 DOI: 10.1002/lary.21727] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
14 Preciado D, Poley M, Tsai S, Tomney A, Brown K, Val S. A proteomic characterization of NTHi lysates. Int J Pediatr Otorhinolaryngol 2016;80:8-16. [PMID: 26746604 DOI: 10.1016/j.ijporl.2015.11.016] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
15 Forgie S, Zhanel G, Robinson J; Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Management of acute otitis media. Paediatrics & Child Health 2009;14:457-60. [DOI: 10.1093/pch/14.7.457] [Cited by in Crossref: 30] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]